A phase II study of liposomal doxorubicin (lipo-dox) in patients with brain metastasis from breast cancer.
Phase of Trial: Phase II
Latest Information Update: 23 May 2018
At a glance
- Drugs Doxorubicin liposomal (Primary)
- Indications Advanced breast cancer; Brain metastases
- Focus Therapeutic Use
- 11 Aug 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 11 Aug 2009 Actual patient number (2) added as reported by ClinicalTrials.gov.
- 10 Jul 2007 New trial record.